Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Immediate effects of upper thoracic spine manipulation on hypertensive individuals.

Ward J, Tyer K, Coats J, Williams G, Kulcak K.

J Man Manip Ther. 2015 Feb;23(1):43-50. doi: 10.1179/1066981714Z.000000000106.

2.

Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries.

Boehler CE, Lord J.

Med Decis Making. 2016 Jan;36(1):31-47. doi: 10.1177/0272989X15579173. Epub 2015 Apr 15.

3.

Impact of Framingham risk score, flow-mediated dilation, pulse wave velocity, and biomarkers for cardiovascular events in stable angina.

Park KH, Han SJ, Kim HS, Kim MK, Jo SH, Kim SA, Park WJ.

J Korean Med Sci. 2014 Oct;29(10):1391-7. doi: 10.3346/jkms.2014.29.10.1391. Epub 2014 Oct 8.

4.

Health-related quality of life in diabetic people with different vascular risk.

Oliva J, Fernández-Bolaños A, Hidalgo A.

BMC Public Health. 2012 Sep 20;12:812. doi: 10.1186/1471-2458-12-812.

6.

The kaiser permanente northwest cardiovascular risk factor management program: a model for all.

Joyce JS, Fetter MM, Klopfenstein DH, Nash MK.

Perm J. 2005 Spring;9(2):19-26.

7.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk.

Quinn RR, Hemmelgarn BR, Padwal RS, Myers MG, Cloutier L, Bolli P, McKay DW, Khan NA, Hill MD, Mahon J, Hackam DG, Grover S, Wilson T, Penner B, Burgess E, McAlister FA, Lamarre-Cliche M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Tobe SW; Canadian Hypertension Education Program..

Can J Cardiol. 2010 May;26(5):241-8. Review.

8.

The relationship between retinal microvascular abnormalities and coronary heart disease: a review.

McClintic BR, McClintic JI, Bisognano JD, Block RC.

Am J Med. 2010 Apr;123(4):374.e1-7. doi: 10.1016/j.amjmed.2009.05.030. Review.

9.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk.

Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McKay DW, Wilson T, Penner B, Burgess E, McAlister FA, Bolli P, Hill MD, Mahon J, Myers MG, Abbott C, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Cloutier L, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Bell C, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad R, Lebel M, Tobe SW; Canadian Hypertension Education Program..

Can J Cardiol. 2009 May;25(5):279-86. Review.

10.
11.

Discussing coronary risk with patients to improve blood pressure treatment: secondary results from the CHECK-UP study.

Grover SA, Lowensteyn I, Joseph L, Kaouache M, Marchand S, Coupal L, Boudreau G.

J Gen Intern Med. 2009 Jan;24(1):33-9. doi: 10.1007/s11606-008-0825-4. Epub 2008 Oct 21.

12.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk.

Padwal RS, Hemmelgarn BR, Khan NA, Grover S, McAlister FA, McKay DW, Wilson T, Penner B, Burgess E, Bolli P, Hill MD, Mahon J, Myers MG, Abbott C, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Cloutier L, Chockalingam A, Rabkin SW, Dawes MD, Touyz RM, Bell C, Burns KD, Ruzicka M, Campbell NR, Lebel M, Tobe SW; Canadian Hypertension Education Program..

Can J Cardiol. 2008 Jun;24(6):455-63. Review.

13.

Perceptions of quality-of-life effects of treatments for diabetes mellitus in vulnerable and nonvulnerable older patients.

Brown SE, Meltzer DO, Chin MH, Huang ES.

J Am Geriatr Soc. 2008 Jul;56(7):1183-90. doi: 10.1111/j.1532-5415.2008.01757.x. Epub 2008 May 19.

15.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

Padwal RS, Hemmelgarn BR, McAlister FA, McKay DW, Grover S, Wilson T, Penner B, Burgess E, Bolli P, Hill M, Mahon J, Myers MG, Abbott C, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Cloutier L, Chockalingam A, Khan NA, Rabkin SW, Dawes M, Touyz RM, Tobe SW; Canadian Hypertension Education Program..

Can J Cardiol. 2007 May 15;23(7):529-38.

16.
17.

Treatment of high blood pressure and gain in event-free life expectancy.

Kassaï B, Boissel JP, Cucherat M, Boutitie F, Gueyffier F.

Vasc Health Risk Manag. 2005;1(2):163-9.

18.

Coronary heart disease policy models: a systematic review.

Unal B, Capewell S, Critchley JA.

BMC Public Health. 2006 Aug 18;6:213. Review.

19.

The role of global risk assessment in hypertension therapy.

Grover SA, Hemmelgarn B, Joseph L, Milot A, Tremblay G.

Can J Cardiol. 2006 May 15;22(7):606-13. Review.

20.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Hemmelgarn BR, McAlister FA, Grover S, Myers MG, McKay DW, Bolli P, Abbott C, Schiffrin EL, Honos G, Burgess E, Mann K, Wilson T, Penner B, Tremblay G, Milot A, Chockalingam A, Touyz RM, Tobe SW; Canadian Hypertension Education Program..

Can J Cardiol. 2006 May 15;22(7):573-81.

Supplemental Content

Support Center